Assessing evidence from clinical trials in chronic hepatitis C

Journal of Viral Hepatitis
Bruce R Bacon

Abstract

Hepatitis C is a global problem with significantly associated morbidity and mortality. Although some recent therapeutic advances have shown rates of sustained virologic remission of 50% or higher, combination therapy with interferon and ribavirin is often not well tolerated and is giving rise to a growing number of nonresponders. As a result, a large number of experimental drugs for the treatment of chronic hepatitis C are in development. As the clinical trial reports are made available, physicians need to become familiar with issues related to the design of these studies and to develop strategies to interpret the evidence they yield. The articles in this supplement describe the issues in clinical trial design and the evaluation of evidence from clinical trials in patients with chronic hepatitis C.

References

Sep 26, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E B Keeffe, F B Hollinger
Aug 19, 1999·The New England Journal of Medicine·M J AlterH S Margolis
Mar 25, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A M Di Bisceglie
Aug 29, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P A LeeJ A Sandberg
Oct 13, 2000·American Journal of Public Health·J B WongT Poynard
Mar 29, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·P E KochB Fang
Nov 14, 2001·Archives of Internal Medicine·J P LeighM Schenker
Mar 22, 2002·Journal of Clinical Gastroenterology·Ramsey C CheungSuzanne M Matsui
Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Oct 3, 2002·Gastroenterology·John G McHutchisonUNKNOWN International Hepatitis Interventional Therapy Group
Oct 22, 2002·The Journal of Pharmacology and Experimental Therapeutics·Blaire L OsbornCynthia Sung
Jun 14, 2003·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Jonathan LarkinJohn I Glass
Oct 8, 2003·Current Drug Targets. Infectious Disorders·Jim Zhen Wu, Zhi Hong
Apr 15, 2004·Gastroenterology Clinics of North America·Peter Hauser
May 11, 2004·Annals of Clinical Microbiology and Antimicrobials·James M McMahonMichael Clatts
Aug 25, 2004·Gastroenterology Clinics of North America·Sangik Oh, Nezam H Afdhal
Nov 25, 2004·Antimicrobial Agents and Chemotherapy·Anita Y M HoweJohn F O'Connell
Mar 26, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Brennan M R SpiegelFasiha Kanwal
Apr 12, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Robert G GishK Rajender Reddy
Jul 19, 2005·Clinics in Liver Disease·Scott W Biggins, Norah A Terrault

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.